| Product Code: ETC7644169 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Acute Myeloid Leukemia Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Acute Myeloid Leukemia Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Acute Myeloid Leukemia Market - Industry Life Cycle |
3.4 Israel Acute Myeloid Leukemia Market - Porter's Five Forces |
3.5 Israel Acute Myeloid Leukemia Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Israel Acute Myeloid Leukemia Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Israel Acute Myeloid Leukemia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Acute Myeloid Leukemia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Acute Myeloid Leukemia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Acute Myeloid Leukemia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of acute myeloid leukemia (AML) in Israel |
4.2.2 Technological advancements in AML diagnosis and treatment |
4.2.3 Growing investments in research and development for AML therapies |
4.3 Market Restraints |
4.3.1 High treatment costs and limited healthcare coverage |
4.3.2 Stringent regulatory requirements for drug approval in Israel |
4.3.3 Limited awareness about AML symptoms leading to delayed diagnosis |
5 Israel Acute Myeloid Leukemia Market Trends |
6 Israel Acute Myeloid Leukemia Market, By Types |
6.1 Israel Acute Myeloid Leukemia Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Myeloblastic, 2021- 2031F |
6.1.4 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Promyelocytic, 2021- 2031F |
6.1.5 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Myelomonocytic, 2021- 2031F |
6.2 Israel Acute Myeloid Leukemia Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.2.4 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2.5 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.2.6 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Acute Myeloid Leukemia Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Acute Myeloid Leukemia Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Acute Myeloid Leukemia Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Israel Acute Myeloid Leukemia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Acute Myeloid Leukemia Market Import-Export Trade Statistics |
7.1 Israel Acute Myeloid Leukemia Market Export to Major Countries |
7.2 Israel Acute Myeloid Leukemia Market Imports from Major Countries |
8 Israel Acute Myeloid Leukemia Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for AML patients in Israel |
8.2 Percentage of AML patients receiving targeted therapy or personalized treatment |
8.3 Number of clinical trials for AML therapies conducted in Israel |
8.4 Survival rates of AML patients in different age groups in Israel |
9 Israel Acute Myeloid Leukemia Market - Opportunity Assessment |
9.1 Israel Acute Myeloid Leukemia Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Israel Acute Myeloid Leukemia Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Israel Acute Myeloid Leukemia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Acute Myeloid Leukemia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Acute Myeloid Leukemia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Acute Myeloid Leukemia Market - Competitive Landscape |
10.1 Israel Acute Myeloid Leukemia Market Revenue Share, By Companies, 2024 |
10.2 Israel Acute Myeloid Leukemia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here